Cargando…

Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer’s disease

BACKGROUND: Tau pathology is a hallmark of Alzheimer’s disease (AD) and other tauopathies. During disease progression, abnormally phosphorylated forms of tau aggregate and accumulate into neurofibrillary tangles, leading to synapse loss, neuroinflammation, and neurodegeneration. Thus, targeting of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Xiao-ying, Li, Ling-jie, Dong, Quan-Xiu, Zhu, Jie, Huang, Ya-ru, Hou, Sheng-jie, Yu, Xiao-lin, Liu, Rui-tian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196535/ https://www.ncbi.nlm.nih.gov/pubmed/34116706 http://dx.doi.org/10.1186/s12974-021-02182-3

Ejemplares similares

Ibrutinib modulates Aβ/tau pathology, neuroinflammation, and cognitive function in mouse models of Alzheimer's disease
por: Lee, Hyun‐ju, et al.
Publicado: (2021)

Sodium rutin ameliorates Alzheimer’s disease–like pathology by enhancing microglial amyloid-β clearance
por: Pan, Rui-Yuan, et al.
Publicado: (2019)

Corrigendum to: Ibrutinib modulates Aβ/tau pathology, neuroinflammation, and cognitive function in mouse models of Alzheimer's disease
Publicado: (2023)

Hepatitis B core VLP-based mis-disordered tau vaccine elicits strong immune response and alleviates cognitive deficits and neuropathology progression in Tau.P301S mouse model of Alzheimer’s disease and frontotemporal dementia
por: Ji, Mei, et al.
Publicado: (2018)

BAD-mediated neuronal apoptosis and neuroinflammation contribute to Alzheimer's disease pathology
por: Zhang, Liansheng, et al.
Publicado: (2021)

Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?
por: Laurent, Cyril, et al.
Publicado: (2018)

Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study
por: Chen, Shi-Dong, et al.
Publicado: (2021)

Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation
por: Chen, Yijun, et al.
Publicado: (2023)

Intravenous Injection of PHF-Tau Proteins From Alzheimer Brain Exacerbates Neuroinflammation, Amyloid Beta, and Tau Pathologies in 5XFAD Transgenic Mice
por: Houben, Sarah, et al.
Publicado: (2020)

Cerebrovascular disease promotes tau pathology in Alzheimer’s disease
por: Laing, Krystal K, et al.
Publicado: (2020)

Neuroinflammation in mouse models of Alzheimer's disease
por: Saito, Takashi, et al.
Publicado: (2018)

Fc effector of anti-Aβ antibody induces synapse loss and cognitive deficits in Alzheimer’s disease-like mouse model
por: Sun, Xiao-ying, et al.
Publicado: (2023)

REAC technology modifies pathological neuroinflammation and motor behaviour in an Alzheimer’s disease mouse model
por: Luca, Lorenzini, et al.
Publicado: (2016)

Neuroprotective Effects of Leptin on the APP/PS1 Alzheimer’s Disease Mouse Model: Role of Microglial and Neuroinflammation
por: Ma, Jing, et al.
Publicado: (2023)

Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer’s Disease
por: Jie, Caitlin V. M. L., et al.
Publicado: (2021)

The neuritic plaque facilitates pathological conversion of tau in an Alzheimer's disease mouse model
por: Li, Tong, et al.
Publicado: (2016)

Tau pathology epigenetically remodels the neuron-glial cross-talk in Alzheimer’s disease
por: Zhou, Lan-Ting, et al.
Publicado: (2023)

Effects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer’s disease
por: Puli, Lakshman, et al.
Publicado: (2012)

Erratum: REAC technology modifies pathological neuroinflammation and motor behaviour in an Alzheimer’s disease mouse model
por: Lorenzini, Luca, et al.
Publicado: (2016)

Agomelatine Prevents Amyloid Plaque Deposition, Tau Phosphorylation, and Neuroinflammation in APP/PS1 Mice
por: Yang, Xiao-bo, et al.
Publicado: (2022)

Marked Mild Cognitive Deficits in Humanized Mouse Model of Alzheimer’s-Type Tau Pathology
por: Cho, Joshua D., et al.
Publicado: (2021)

Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer’s disease
por: Gibbons, Garrett S., et al.
Publicado: (2020)

Unique pathological tau conformers from Alzheimer’s brains transmit tau pathology in nontransgenic mice
por: Guo, Jing L., et al.
Publicado: (2016)

Structure and Pathology of Tau Protein in Alzheimer Disease
por: Kolarova, Michala, et al.
Publicado: (2012)

Microglia in Alzheimer’s Disease in the Context of Tau Pathology
por: Perea, Juan Ramón, et al.
Publicado: (2020)

Impact of Tau on Neurovascular Pathology in Alzheimer's Disease
por: Canepa, Elisa, et al.
Publicado: (2021)

Alzheimer's Disease: Tau Pathology and Dysfunction of Endocytosis
por: Ando, Kunie, et al.
Publicado: (2021)

Tau Overexpression Impacts a Neuroinflammation Gene Expression Network Perturbed in Alzheimer’s Disease
por: Wes, Paul D., et al.
Publicado: (2014)

Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment
por: Chandra, Avinash, et al.
Publicado: (2019)

Vascular smooth muscle cell dysfunction contribute to neuroinflammation and Tau hyperphosphorylation in Alzheimer disease
por: Aguilar-Pineda, Jorge A., et al.
Publicado: (2021)

A Diet Containing Rutin Ameliorates Brain Intracellular Redox Homeostasis in a Mouse Model of Alzheimer’s Disease
por: Bermejo-Bescós, Paloma, et al.
Publicado: (2023)

Experimental Diabetes Mellitus Exacerbates Tau Pathology in a Transgenic Mouse Model of Alzheimer's Disease
por: Ke, Yazi D., et al.
Publicado: (2009)

Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau
por: Lasagna-Reeves, Cristian A., et al.
Publicado: (2012)

Phospho-Tau and Cognitive Decline in Alzheimer's Disease. Commentary: Tau in physiology and pathology
por: DeFelipe, Javier
Publicado: (2016)

Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer's Disease Brain
por: DeVos, Sarah L., et al.
Publicado: (2018)

PHF-Core Tau as the Potential Initiating Event for Tau Pathology in Alzheimer’s Disease
por: Luna-Viramontes, Nabil Itzi, et al.
Publicado: (2020)

Prevention of selenite-induced cataractogenesis by rutin in Wistar rats
por: Isai, M., et al.
Publicado: (2009)

Neuroinflammation and neurohormesis in the pathogenesis of Alzheimer’s disease and Alzheimer-linked pathologies: modulation by nutritional mushrooms
por: Trovato Salinaro, Angela, et al.
Publicado: (2018)

Loss of PAFR prevents neuroinflammation and brain dysfunction after traumatic brain injury
por: Yin, Xiang-Jie, et al.
Publicado: (2017)

PET Imaging of Tau Pathology in Alzheimer’s Disease and Tauopathies
por: James, Olga G., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cfu2ki21fu515ebaris3njiu56